HomeCompareMAYNF vs GBDC

MAYNF vs GBDC: Dividend Comparison 2026

MAYNF yields 121.95% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $11.58M in total portfolio value· pulled ahead in Year 10
10 years
MAYNF
MAYNF
● Live price
121.95%
Share price
$1.64
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.20M
Annual income
$3,519,740.94
Full MAYNF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — MAYNF vs GBDC

📍 GBDC pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAYNFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAYNF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MAYNF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAYNF
Annual income on $10K today (after 15% tax)
$10,365.85/yr
After 10yr DRIP, annual income (after tax)
$2,991,779.80/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $10,939,094.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAYNF + GBDC for your $10,000?

MAYNF: 50%GBDC: 50%
100% GBDC50/50100% MAYNF
Portfolio after 10yr
$14.99M
Annual income
$9,954,502.17/yr
Blended yield
66.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

MAYNF
No analyst data
Altman Z
-0.6
Piotroski
5/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAYNF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAYNFGBDC
Forward yield121.95%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$9.20M$20.78M
Annual income after 10y$3,519,740.94$16,389,263.41
Total dividends collected$8.37M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MAYNF vs GBDC ($10,000, DRIP)

YearMAYNF PortfolioMAYNF Income/yrGBDC PortfolioGBDC Income/yrGap
1$22,895$12,195.12$12,490$1,790.28+$10.4KMAYNF
2$50,592$26,094.28$16,522$3,157.73+$34.1KMAYNF
3$108,023$53,889.10$23,578$5,898.68+$84.4KMAYNF
4$223,119$107,534.91$37,115$11,886.75+$186.0KMAYNF
5$446,319$207,581.09$66,136$26,423.57+$380.2KMAYNF
6$865,633$388,071.89$137,257$66,491.44+$728.4KMAYNF
7$1,629,651$703,423.94$341,734$194,868.54+$1.29MMAYNF
8$2,981,366$1,237,639.89$1,050,788$685,133.02+$1.93MMAYNF
9$5,306,138$2,116,076.08$4,099,314$2,974,971.01+$1.21MMAYNF
10← crossover$9,197,309$3,519,740.94$20,775,530$16,389,263.41$11.58MGBDC

MAYNF vs GBDC: Complete Analysis 2026

MAYNFStock

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Full MAYNF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this MAYNF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAYNF vs SCHDMAYNF vs JEPIMAYNF vs OMAYNF vs KOMAYNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.